{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:25:55Z","timestamp":1776212755155,"version":"3.50.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"crossref","award":["H30-Sinkogyousei-Shitei-10109700"],"award-info":[{"award-number":["H30-Sinkogyousei-Shitei-10109700"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18fk0108070j0101"],"award-info":[{"award-number":["18fk0108070j0101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18fk0108072j0001"],"award-info":[{"award-number":["18fk0108072j0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0223684","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T17:23:53Z","timestamp":1570469033000},"page":"e0223684","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0704-9611","authenticated-orcid":true,"given":"Hirofumi","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-4165","authenticated-orcid":true,"given":"Mutsuyo","family":"Takayama-Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itoe","family":"Iizuka-Shiota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuetsu","family":"Fukushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1622-8571","authenticated-orcid":true,"given":"Guillermo","family":"Posadas-Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Horiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuko","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Shibamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinjiro","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-7298","authenticated-orcid":true,"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Kweng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"pone.0223684.ref001","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East Respiratory Syndrome","volume":"386","author":"A Zumla","year":"2015","journal-title":"Lancet"},{"key":"pone.0223684.ref002","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East Respiratory Syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"JFW Chan","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"pone.0223684.ref003","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"AM Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0223684.ref004","unstructured":"World Health Organization. Middle East Respiratory Syndrome coronavirus (MERS-CoV). [cited 2019 May 9]. http:\/\/www.who.int\/emergencies\/mers-cov\/en\/."},{"key":"pone.0223684.ref005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.phrp.2016.01.001","article-title":"The characteristics of Middle Eastern Respiratory Syndrome coronavirus transmission dynamics in South Korea","volume":"7","author":"Y Kim","year":"2016","journal-title":"Osong Public Health Res Perspect"},{"key":"pone.0223684.ref006","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.vaccine.2016.03.104","article-title":"MERS-CoV vaccine candidates in development: The current landscape","volume":"34","author":"K Modjarrad","year":"2016","journal-title":"Vaccine"},{"key":"pone.0223684.ref007","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrmicro3143","article-title":"A decade after SARS: strategies for controlling emerging coronaviruses","volume":"11","author":"RL Graham","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"pone.0223684.ref008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"VS Raj","year":"2013","journal-title":"Nature"},{"key":"pone.0223684.ref009","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/JVI.02615-14","article-title":"Receptor recognition mechanisms of coronaviruses: a decade of structural studies","volume":"89","author":"F Li","year":"2015","journal-title":"J Virol"},{"key":"pone.0223684.ref010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"G Lu","year":"2013","journal-title":"Nature"},{"key":"pone.0223684.ref011","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East Respiratory Syndrome coronavirus as an essential target for vaccine development","volume":"87","author":"L Du","year":"2013","journal-title":"J Virol"},{"key":"pone.0223684.ref012","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"L Du","year":"2013","journal-title":"PLoS One"},{"key":"pone.0223684.ref013","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2014.02.004","article-title":"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines","volume":"32","author":"C Ma","year":"2014","journal-title":"Vaccine"},{"key":"pone.0223684.ref014","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2017.12.007","article-title":"A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization","volume":"150","author":"R Liu","year":"2018","journal-title":"Antiviral Res"},{"key":"pone.0223684.ref015","doi-asserted-by":"crossref","first-page":"e02040","DOI":"10.1128\/JVI.02040-16","article-title":"One-Health: a safe, efficient, dual-use vaccine for humans and animals against Middle East Respiratory Syndrome coronavirus and rabies virus","volume":"91","author":"C Wirblich","year":"2017","journal-title":"J Virol"},{"key":"pone.0223684.ref016","volume-title":"Fields Virology","author":"DM Knipe","year":"2013"},{"key":"pone.0223684.ref017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/187152611795768079","article-title":"Human rabies encephalitis prevention and treatment: progress since Pasteur\u2019s discovery","volume":"11","author":"L Dacheux","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"pone.0223684.ref018","first-page":"77","article-title":"Human rabies: 2016 updates and call for data","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"pone.0223684.ref019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-387040-7.00009-3","article-title":"Rabies virus as a research tool and viral vaccine vector","volume":"79","author":"EA Gomme","year":"2011","journal-title":"Adv Virus Res"},{"key":"pone.0223684.ref020","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1128\/JVI.72.3.1925-1930.1998","article-title":"Mapping the interacting domains between the rabies virus polymerase and phosphoprotein","volume":"72","author":"M Chenik","year":"1998","journal-title":"J Virol"},{"key":"pone.0223684.ref021","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/viro.1995.0063","article-title":"Polymerase activity of in vitro mutated rabies virus L protein","volume":"214","author":"MJ Schnell","year":"1995","journal-title":"Virology"},{"key":"pone.0223684.ref022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2005.03.011","article-title":"Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity","volume":"111","author":"K Morimoto","year":"2005","journal-title":"Virus Res"},{"key":"pone.0223684.ref023","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","article-title":"Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G","volume":"73","author":"T Mebatsion","year":"1999","journal-title":"J Virol"},{"key":"pone.0223684.ref024","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication\u2010deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates","volume":"200","author":"J Cenna","year":"2009","journal-title":"J Infect Dis"},{"key":"pone.0223684.ref025","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1348-0421.2005.tb03692.x","article-title":"Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain","volume":"49","author":"N Ito","year":"2005","journal-title":"Microbiol Immunol"},{"key":"pone.0223684.ref026","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.virol.2003.10.001","article-title":"Generation and characterization of P gene-deficient rabies virus","volume":"318","author":"Y Shoji","year":"2004","journal-title":"Virology"},{"key":"pone.0223684.ref027","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"MJ Schnell","year":"1994","journal-title":"EMBO J"},{"key":"pone.0223684.ref028","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"T Mebatsion","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0223684.ref029","doi-asserted-by":"crossref","first-page":"e0006398","DOI":"10.1371\/journal.pntd.0006398","article-title":"Replication-incompetent rabies virus vector harboring Glycoprotein gene of Lymphocytic Choriomeningitis Virus (LCMV) protects mice from lethal LCMV challenge","volume":"16","author":"M Takayama-Ito","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0223684.ref030","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1073\/pnas.97.7.3544","article-title":"Recombinant rabies virus as potential live-viral vaccines for HIV-1","volume":"97","author":"MJ Schnell","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0223684.ref031","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"M Faber","year":"2005","journal-title":"J Gen Virol"},{"key":"pone.0223684.ref032","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"KK Conzelmann","year":"1990","journal-title":"Virology"},{"key":"pone.0223684.ref033","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.1073\/pnas.011510698","article-title":"A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection","volume":"97","author":"HD Foley","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0223684.ref034","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1128\/JVI.77.20.10889-10899.2003","article-title":"Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome","volume":"77","author":"JP McGettigan","year":"2003","journal-title":"J Virol"},{"key":"pone.0223684.ref035","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"JP McGettigan","year":"2001","journal-title":"J Virol"},{"key":"pone.0223684.ref036","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"JP McGettigan","year":"2003","journal-title":"J Virol"},{"key":"pone.0223684.ref037","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/S0264-410X(01)00186-4","article-title":"Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination","volume":"19","author":"LA Orciari","year":"2001","journal-title":"Vaccine"},{"key":"pone.0223684.ref038","first-page":"6136","article-title":"Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing","volume":"30","author":"AB Papaneri","year":"2012","journal-title":"Ebola virus glycoprotein"},{"key":"pone.0223684.ref039","first-page":"94","article-title":"Studies on chick-embryo-adapted-rabies virus. VI. Further changes in pathogenic properties following prolonged cultivation in the developing chick embryo","volume":"72","author":"H Koprowski","year":"1954","journal-title":"J Immunol"},{"key":"pone.0223684.ref040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-0934(02)00249-5","article-title":"An improved method for recovering rabies virus from cloned cDNA","volume":"107","author":"K Inoue","year":"2003","journal-title":"J Virol Methods"},{"key":"pone.0223684.ref041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2017.10.008","article-title":"Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA","volume":"251","author":"S Fukushi","year":"2018","journal-title":"J Virol Methods"},{"key":"pone.0223684.ref042","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-1702(97)00080-4","article-title":"A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope","volume":"51","author":"TR Luo","year":"1997","journal-title":"Virus Res"},{"key":"pone.0223684.ref043","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7883\/yoken.JJID.2015.094","article-title":"Middle East Respiratory Syndrome coronavirus infection not found in camels in Japan","volume":"68","author":"K Shirato","year":"2015","journal-title":"Jpn J Infect Dis"},{"key":"pone.0223684.ref044","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jmv.20732","article-title":"Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV","volume":"78","author":"S Fukushi","year":"2006","journal-title":"J Med Virol"},{"key":"pone.0223684.ref045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biologicals.2009.01.001","article-title":"The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines","volume":"37","author":"B Kr\u00e4mer","year":"2009","journal-title":"Biologicals"},{"key":"pone.0223684.ref046","first-page":"37","article-title":"Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use","volume":"2010","author":"B Kr\u00e4mer","year":"2010","journal-title":"Pharmeur Bio Sci Notes"},{"key":"pone.0223684.ref047","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/21645515.2017.1389362","article-title":"Development of Middle East Respiratory Syndrome coronavirus vaccines\u2013advances and challenges","volume":"14","author":"H Cho","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"pone.0223684.ref048","doi-asserted-by":"crossref","first-page":"e1917","DOI":"10.1002\/rmv.1917","article-title":"Vaccines against Middle East Respiratory Syndrome coronavirus for humans and camels","volume":"27","author":"NK Alharbi","year":"2017","journal-title":"Rev Med Virol"},{"key":"pone.0223684.ref049","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East Respiratory Syndrome coronavirus spike protein delivered by Modified Vaccinia Virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"F Song","year":"2013","journal-title":"J Virol"},{"key":"pone.0223684.ref050","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01815-15","article-title":"A highly immunogenic and protective Middle East Respiratory Syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform","volume":"89","author":"AH Malczyk","year":"2015","journal-title":"J Virol"},{"key":"pone.0223684.ref051","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.12462","article-title":"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East Respiratory Syndrome coronavirus","volume":"145","author":"X Guo","year":"2015","journal-title":"Immunology"},{"key":"pone.0223684.ref052","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"E Kim","year":"2014","journal-title":"Vaccine"},{"key":"pone.0223684.ref053","doi-asserted-by":"crossref","first-page":"e1003389","DOI":"10.1371\/journal.ppat.1003389","article-title":"Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine","volume":"9","author":"JE Blaney","year":"2013","journal-title":"PLoS Pathog"},{"key":"pone.0223684.ref054","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"CA Siler","year":"2002","journal-title":"Virology"},{"key":"pone.0223684.ref055","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Y Li","year":"2015","journal-title":"Cell Res"},{"key":"pone.0223684.ref056","doi-asserted-by":"crossref","DOI":"10.3201\/eid2207.160022","article-title":"Development of medical countermeasures to Middle East Respiratory Syndrome coronavirus","volume":"22","author":"TM Uyeki","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"pone.0223684.ref057","first-page":"201","article-title":"Rabies vaccines: WHO position paper\u2013April 2018","volume":"16","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"pone.0223684.ref058","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2012.07.020","article-title":"A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence","volume":"434","author":"AB Papaneri","year":"2012","journal-title":"Virology"},{"key":"pone.0223684.ref059","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"JE Blaney","year":"2011","journal-title":"J Virol"},{"key":"pone.0223684.ref060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4142\/jvs.2017.18.S1.351","article-title":"Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levels","volume":"18","author":"GM Yu","year":"2017","journal-title":"J Vet Sci"},{"key":"pone.0223684.ref061","doi-asserted-by":"crossref","first-page":"44875","DOI":"10.1038\/srep44875","article-title":"Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein","volume":"7","author":"SS Al-Amri","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0223684.ref062","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.vaccine.2017.02.063","article-title":"DNA vaccine encoding Middle East Respiratory Syndrome coronavirus S1 protein induces protective immune responses in mice","volume":"35","author":"H Chi","year":"2017","journal-title":"Vaccine"},{"key":"pone.0223684.ref063","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"E Kim","year":"2014","journal-title":"Vaccine"},{"key":"pone.0223684.ref064","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1128\/JVI.00983-14","article-title":"Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB\/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine","volume":"88","author":"N Iwata-Yoshikawa","year":"2014","journal-title":"J Virol"},{"key":"pone.0223684.ref065","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3201\/eid2008.140590","article-title":"Geographic distribution of MERS coronavirus among dromedary camels, Africa","volume":"20","author":"CBEM Reusken","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"pone.0223684.ref066","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1473-3099(13)70164-6","article-title":"Middle East Respiratory Syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study","volume":"13","author":"CB Reusken","year":"2013","journal-title":"Lancet Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0223684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T08:31:31Z","timestamp":1611477091000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0223684"}},"subtitle":[],"editor":[{"given":"Paulo Lee","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0223684","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]}}}